REVEAL-CP: Selective Screening of Pediatric Patients for Aromatic L -Amino Acid Decarboxylase Deficiency with a Guthrie Card and In Silico Structural Modeling of One Index Case
Genetic Testing and Molecular Biomarkers · 2025
DOI: 10.1089/gtmb.2024.0427 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Genetic Testing and Molecular Biomarkers, 2025. Verfasst von Eugen-Matthias Strehle und 12 weiteren Autor:innen. Beteiligte Einrichtung: Northumbria Healthcare NHS Foundation Trust, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: Aromatic-L-Amino-Acid Decarboxylases, Amino Acid Metabolism, Inborn Errors. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The main objective of this prospective, multicenter study (REVEAL-CP) was to test children with cerebral palsy-like signs and symptoms for raised 3- O -methyldopa (3-OMD) blood levels, a biomarker for aromatic L -amino acid decarboxylase deficiency (AADCd). A secondary objective was to characterize the molecular basis for the defective aromatic L -amino acid decarboxylase (AADC) gene product.
Methods
Patients were identified in pediatric secondary and tertiary care hospitals through database searches and personal communication. 3-OMD concentrations from Guthrie card tests were determined using liquid chromatography/mass spectrometry. If 3-OMD was raised, cerebrospinal fluid analysis and dopa decarboxylase ( DDC ) gene sequencing were performed. An in-silico mutagenesis analysis was carried out to model altered AADC enzymes.
Results
In total, 166 patients were enrolled in this study. The median age was 8 years. Sixty-six patients (39.8%) had a diagnosis of cerebral palsy, with the most common type being “mixed” ( n = 42; 25.3%). One patient (0.6%), an 11-month-old boy from Italy, was diagnosed with AADCd caused by a homozygous, pathogenic DDC variant (c.749C>T; p.Ser250Phe). Three-dimensional modeling of the Ser250Phe AADC enzyme variant revealed its destabilization.
Conclusions
A Guthrie card test for 3-OMD is a recognized screening technique for AADCd. If universal newborn screening for this metabolic disease is not available, children with signs and symptoms of a movement disorder should be investigated for AADCd.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Northumbria Healthcare NHS Foundation Trust, Newcastle upon Tyne, UK.
- The Medical School, Newcastle University, Newcastle upon Tyne, UK.
- IRCCS Stella Maris Foundation, Pisa, Italy.
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
- Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
- Hôpital Femme-Enfant-Adolescent, Centre Hospitalier Universitaire de Nantes, Nantes, France.
ORCID-Profile: Eugen-Matthias Strehle, Mariarita Bertoldi, Christian Werner
Zitieren
APA
Strehle, E. M., Battini, R., Gowda, V., Kuster, A., Amin, S., Bertoldi, M., Perduca, M., Leuzzi, V., Johnson, S., Lupo, P., Liu, E., Fox, E., & Werner, C. (2025). REVEAL-CP: Selective Screening of Pediatric Patients for Aromatic L -Amino Acid Decarboxylase Deficiency with a Guthrie Card and In Silico Structural Modeling of One Index Case. Genetic Testing and Molecular Biomarkers. https://doi.org/10.1089/gtmb.2024.0427
Vancouver
Strehle EM, Battini R, Gowda V, Kuster A, Amin S, Bertoldi M, et al. REVEAL-CP: Selective Screening of Pediatric Patients for Aromatic L -Amino Acid Decarboxylase Deficiency with a Guthrie Card and In Silico Structural Modeling of One Index Case. Genetic Testing and Molecular Biomarkers. 2025. doi:10.1089/gtmb.2024.0427
BibTeX
@article{Strehle2025,
author = {Strehle, Eugen-Matthias and Battini, Roberta and Gowda, Vasantha and Kuster, Alice and Amin, Sam and Bertoldi, Mariarita and Perduca, Massimiliano and Leuzzi, Vincenzo and Johnson, Shelley and Lupo, Paul and Liu, Emelline and Fox, Emily and Werner, Christian},
title = {REVEAL-CP: Selective Screening of Pediatric Patients for Aromatic L -Amino Acid Decarboxylase Deficiency with a Guthrie Card and In Silico Structural Modeling of One Index Case},
journal = {Genetic Testing and Molecular Biomarkers},
year = {2025},
doi = {10.1089/gtmb.2024.0427}
}
EUVIMED